News | June 02, 2022
Vial to launch oncology CRO, Arati Rao named as First Advisor
The new Oncology CRO will aim to drive faster execution and higher quality trial outcomes for Oncology sponsors.
The new Oncology CRO will aim to drive faster execution and higher quality trial outcomes for Oncology sponsors.
Besides enhancing workflow operations by connecting scientists with their lab instruments and data, digitalization holds the potential to acceleratee long-term business growth
As per partnership, Carbanio will arrange raw materials and other custom chemicals for Proexp Pharma Pvt. Ltd. through an uninterrupted digital process of the company
Low-dose atropine has emerged as an effective approach to slow the progression of myopia in children
Evrysdi has proven efficacy in babies, children and adults with more than 5,000 patients treated to date
This agreement is in addition to the $92 million filling line expansion announced in November 2021
Dr Jitendra Singh said, the Biotech Park would act as a hub for incubation of new ideas
68% of patients receiving Kymriah in the ELARA trial experienced a complete response, with an 86% overall response rate, along with a remarkable safety profile
Researchers found that the drug combination led to a sustained and tenfold increase in the production of CD8 T cells and natural killer cells
Perrigo expects to launch Omeprazole Minis later this year
Subscribe To Our Newsletter & Stay Updated
